|
| Shares or
Principal
Amount
| Value
|
| Convertible Preferred Stocks(a),(b),(c)—3.2%
|
| Biotechnology—2.2%
|
| Abcuro, Inc. Series B
|
| 601,124
| $ 3,299,990
|
| Abcuro, Inc. Series C1
|
| 133,045
| 803,419
|
| Atalanta Therapeutics, Inc. Series B
|
| 1,944,444
| 1,750,000
|
| Glycomine, Inc. Series C, 8.00%
|
| 6,872,036
| 4,123,222
|
| Seismic Therapeutics, Inc. Series B
|
| 730,764
| 3,299,984
|
| Third Arc Bio, Inc. Series A, 8.00%
|
| 2,091,056
| 4,400,000
|
|
|
|
| 17,676,615
|
| Health Care Equipment & Supplies—0.0%
|
| IO Light Holdinigs, Inc. Series A2
|
| 189,858
| 19
|
| Pharmaceuticals—1.0%
|
| Crystalys Therapeutics, Inc. Series A
|
| 2,508,159
| 2,512,799
|
| Endeavor Group Holdings, Inc. Series B, 8.00%
|
| 742,138
| 3,499,997
|
| Endeavor Group Holdings, Inc. Series C, 8.00%
|
| 137,039
| 894,125
|
| Engrail Therapeutics, Inc., 8.00%
|
| 1,652,502
| 985,056
|
|
|
|
| 7,891,977
|
| Total Convertible Preferred Stocks
| 25,568,611
|
| Non-Convertible Notes—18.8%
|
|
|
|
| Biotechnology—3.3%
|
| AbbVie, Inc., 3.20%, 05/14/26
|
| $ 3,245,000
| 3,237,740
|
| AbbVie, Inc., 4.25%, 11/14/28
|
| 5,303,000
| 5,361,760
|
| AbbVie, Inc., 4.45%, 05/14/46
|
| 3,080,000
| 2,677,085
|
| Amgen, Inc., 3.20%, 11/02/27
|
| 2,200,000
| 2,172,146
|
| Amgen, Inc., 2.00%, 01/15/32
|
| 2,795,000
| 2,435,067
|
| Gilead Sciences, Inc., 2.95%, 03/01/27
|
| 10,000,000
| 9,901,775
|
|
|
|
| 25,785,573
|
| Health Care Equipment & Supplies—3.0%
|
| Abbott Laboratories, 4.75%, 11/30/36
|
| 10,498,000
| 10,562,479
|
| Becton Dickinson & Co., 3.70%, 06/06/27
|
| 2,413,000
| 2,402,916
|
| DH Europe Finance II SARL, 3.25%, 11/15/39
|
| 1,760,000
| 1,441,586
|
| Stryker Corp., 3.65%, 03/07/28
|
| 3,500,000
| 3,480,139
|
| Zimmer Biomet Holdings, Inc., 4.25%, 08/15/35
|
| 6,000,000
| 5,577,708
|
|
|
|
| 23,464,828
|
| Health Care Providers & Services—7.4%
|
| Cigna Group, 4.38%, 10/15/28
|
| 1,504,000
| 1,517,672
|
| Cigna Group, 2.38%, 03/15/31
|
| 5,800,000
| 5,249,473
|
| Cigna Group, 6.13%, 11/15/41
|
| 8,250,000
| 8,722,777
|
| CVS Health Corp., 4.30%, 03/25/28
|
| 789,000
| 791,613
|
| CVS Health Corp., 1.88%, 02/28/31
|
| 4,400,000
| 3,860,541
|
| CVS Health Corp., 4.78%, 03/25/38
|
| 2,100,000
| 1,982,214
|
| CVS Health Corp., 5.05%, 03/25/48
|
| 3,700,000
| 3,261,734
|
| Elevance Health, Inc., 4.10%, 03/01/28
|
| 2,975,000
| 2,977,802
|
| Elevance Health, Inc., 2.55%, 03/15/31
|
| 5,800,000
| 5,295,387
|
| Elevance Health, Inc., 4.65%, 08/15/44
|
| 2,325,000
| 2,049,131
|
| UnitedHealth Group, Inc., 3.85%, 06/15/28
|
| 1,460,000
| 1,458,454
|
| UnitedHealth Group, Inc., 3.88%, 12/15/28
|
| 4,970,000
| 4,966,166
|
| UnitedHealth Group, Inc., 4.20%, 05/15/32
|
| 10,940,000
| 10,800,799
|
| UnitedHealth Group, Inc., 4.50%, 04/15/33
|
| 5,800,000
| 5,766,772
|
|
|
|
| 58,700,535
|